Drugs Made In America Acquisition II Corp. (DMII): debt financing — Drugs Made In America Acquisition II Corp. issues $150K convertible bridge note as part of $1.4M financing

Drugs Made In America Acquisition II Corp.

On March 11, 2026, Company issued a $150,000 unsecured convertible bridge note to Alpha Multi Family Office (Investor).
The bridge note is part of a larger $1,400,000 convertible notes financing under a Letter of Intent dated March 5, 2026 and an addendum dated March 9, 2026.
The note matures nine months from issuance, bears no interest, and is convertible at a 35% discount to market price upon a business combination.
The Company plans to use proceeds for accounting, audit, and other expenses related to the business combination.
The LOI originally contemplated $1,500,000 but was reduced to $1,400,000 after $100,000 in advisor fees.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Drugs Made In America Acquisition II Corp. incurred convertible notes of $150,000 with Alpha Multi Family Office at does not bear interest maturing nine months from the date of issuance.

Instrument: convertible notes
Principal: $150,000
Counterparty: Alpha Multi Family Office
Rate: does not bear interest
Maturity: nine months from the date of issuance
Event: incurrence

Exact text from the filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Drugs Made In America Acquisition II Corp. entered into Bridge Note with Alpha Multi Family Office valued at $150,000 (effective 2026-03-11).

Action: entry
Agreement: notes offering
Counterparty: Alpha Multi Family Office
Value: $150,000
Effective: 2026-03-11

Exact text from the filing

On March 11, 2026, Drugs Made In America Acquisition II Corp. (the “ Company ”) issued an unsecured convertible note (the “ Bridge Note ”) to Alpha Multi Family Office (the “ Investor ”) in the principal amount of $150,000 (the “ Bridge Loan ”).

View on SEC.gov

7 debt financings filed in the last 30 days. Browse all debt financings →

Drugs Made In America Acquisition II Corp. filing history →

Source: SEC EDGAR

accession 0001213900-26-029050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.